Breast Cancer Highlights From ASCO 2026: ADCs, Biomarkers, and Earlier Treatment Strategies Take Center Stage
Amol Akhade: What The Devil Wears Prada 2 Taught Me About Oncology?
Alexandre Chan: Real-World Safety of Antibody–Drug Conjugates
Christopher Jackson: If Innovation Is the Heart of Oncology, Then Access Must Be Its Conscience
Khizra Ahmad: Covering ASCO26 from Front-Row Seat as OncoDaily Ambassador
IMMUNIB Study Uptades: Nivolumab Plus Lenvatinib in Unresectable HCC
Hesham ElGhazaly: Meeting Global Oncology Leaders at ASCO 2026
ESTRO-EORTC Expert Guideline on Target Delineation and Radiotherapy for Stage I–III Small Cell Lung Cancer
Track cumulative cisplatin exposure (mg/m²) and view evidence-based risk flags for ototoxicity and renal injury.
Can be calculated from BSA calculator
Pediatric thresholds: ≥360 mg/m² higher risk
Risk Thresholds:
